✓ Effective for patients whose persistent LUTS and particularly OAB was not controlled with alpha1 -adrenergic receptor blocker monotherapy
✓ Has shown improvement in symptoms based on reductions in frequency, urgency, and incontinence episodes, along with other subjective OAB tests